Skip to content Skip to menu

Medicines Australia announce the resignation of CEO, Milton Catelin

Tuesday, 13 March 2018

Media Release

Medicines Australia CEO Milton Catelin today announced his resignation from the peak body representing the innovative medicines industry, ahead of a move back to the United Kingdom (UK).

Medicines Australia Chairman Wes Cook thanked Milton, stating, “On behalf of the Board and our members I would like to thank Milton Catelin for his contribution to the innovative medicines industry.”

‘Milton is leaving Medicines Australia following a period of significant transformation and growth for our sector.”

“As an industry body we have benefited from his leadership of a highly experienced team who together have delivered meaningful health policy outcomes, for example the successful negotiation of the modification of the Government’s skilled migration occupation lists.”

“Milton has also worked closely with the members of the Medicines Australia secretariat and member companies to build strong and meaningful partnerships with our stakeholders, culminating in the highly engaging PharmAus event at Parliament House in September last year”, Mr Cook said.

Milton Catelin thanked the Board for their support over the past 18 months.

“As a group of highly engaged Managing Directors, they have worked cohesively to support myself and the secretariat to achieve some outstanding outcomes,” said Mr Catelin.

“I leave medicines Australia and the innovative medicines industry at a time of great strength. We’ve worked hard to establish the Strategic Agreement and developed firm partnerships with Government. Importantly, we have also mobilised and united as a membership like never before,” he said.

“I am privileged to have been able to contribute to this extraordinary sector,”

“I’d also like to thank the MA secretariat and wider membership for their commitment. Throughout my tenure, I have witnessed a passion and dedication that highlights how meaningful this industry is to the health of Australians,” Mr Catelin said.

Looking forward, Mr Cook said, “Today, with a highly engaged membership and experienced Secretariat, Medicines Australia is incredibly well positioned to contribute to the development of good health policy in Australia.

“I sincerely wish Milton all the very best on his future and his important move back to the UK to join his family,” concluded Mr Cook.

A sub-committee of the Medicines Australia Board will now commence a process to recruit a new CEO.

 

-Ends-

More information: Natalie Wimmer – Communications Manager, Medicines Australia

Ph: 0450 728 660

E: nwimmer@medaus.com.au

Information

As COVID19 continues to spread, our thoughts go out to anyone who has been infected or impacted. We hope that you are taking the necessary precautions to keep safe and well, both at work and at home.

Medicines Australia continues to monitor the situation and take advice from the Department of Health and the World Health Organisation. We are focused on responding to the important short-term issues but are also ensuring we stay balanced and maintain a focus on the medium and long-term business for our industry along with the well-being of our people.

At Medicines Australia we have initiated the following to ensure we support containment measures to provide business continuity and the well-being of our staff.

  • All non-essential travel has been restricted or cancelled
  • All face-to-face meetings (with external stakeholders and members) have been changed to virtual meetings (where appropriate)
  • Staff have been provided with the latest official information on COVID-19 through a hot-link on the office intranet; this information is regularly monitored and updated
  • Flexible working arrangements are covered in our HR policy which will allow staff to work remotely, if or when required
  • Current IT infrastructure enables staff to work remotely and will be in use if any person needs to self-isolate
  • Visual reminders have been displayed around the office, providing information about best hygiene practices
  • Extra hand-sanitiser, tissues and cleaning products have been supplied to staff for their work spaces

Our latest information is located at medicinesaustralia.com.au/covid-19/

Top